- Home
- ICCC vs FGF Comparison
ICCC vs FGF Comparison
Compare ICCC & FGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- FGF
- Stock Information
- Founded
- ICCC 1982
- FGF 2012
- Country
- ICCC United States
- FGF United States
- Employees
- ICCC N/A
- FGF N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- FGF Property-Casualty Insurers
- Sector
- ICCC Health Care
- FGF Finance
- Exchange
- ICCC Nasdaq
- FGF Nasdaq
- Market Cap
- ICCC 28.0M
- FGF 28.0M
- IPO Year
- ICCC 1987
- FGF N/A
- Fundamental
- Price
- ICCC $4.71
- FGF $22.00
- Analyst Decision
- ICCC
- FGF
- Analyst Count
- ICCC 0
- FGF 0
- Target Price
- ICCC N/A
- FGF N/A
- AVG Volume (30 Days)
- ICCC 22.4K
- FGF 35.6K
- Earning Date
- ICCC 11-13-2024
- FGF 11-14-2024
- Dividend Yield
- ICCC N/A
- FGF N/A
- EPS Growth
- ICCC N/A
- FGF N/A
- EPS
- ICCC N/A
- FGF N/A
- Revenue
- ICCC $23,838,001.00
- FGF $22,351,000.00
- Revenue This Year
- ICCC N/A
- FGF N/A
- Revenue Next Year
- ICCC N/A
- FGF N/A
- P/E Ratio
- ICCC N/A
- FGF N/A
- Revenue Growth
- ICCC 46.37
- FGF N/A
- 52 Week Low
- ICCC $3.34
- FGF $14.21
- 52 Week High
- ICCC $5.82
- FGF $40.75
- Technical
- Relative Strength Index (RSI)
- ICCC 56.95
- FGF 39.24
- Support Level
- ICCC $4.38
- FGF $21.00
- Resistance Level
- ICCC $5.23
- FGF $26.00
- Average True Range (ATR)
- ICCC 0.47
- FGF 3.27
- MACD
- ICCC -0.04
- FGF -0.99
- Stochastic Oscillator
- ICCC 22.92
- FGF 6.33
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About FGF FG Financial Group Inc. (NV)
Fundamental Global Inc through its subsidiaries operates as diversified insurance, reinsurance, and investment management holding company. The company's segment includes Insurance and Asset Management. It generates maximum revenue from the Insurance segment.